诱导化疗在头颈部癌的应用已多年,虽取得一定成绩,但经近年较多随机试验研究,基本表明现有化疗方案不能提高生存率,目前已趋向于重在据其对癌瘤的缓解程度,选择适宜于器官(尤其喉)保存的病例,成为诱导化疗在头颈癌应用的一个新动态。 Induction chemotherapy has been used in head and neck cancer for many years. Although it has achieved certain results, but in recent years, a number of randomized trials have basically shown that the existing chemotherapy can not improve the survival rate, has now tended to focus on the remission of cancer. Degree, selecting cases suitable for organ (especially laryngeal) preservation has become a new development in the application of induction chemotherapy in head and neck cancer.